Sidgwick's Ethics (Cambridge: Cambridge University Press, forthcoming 2021).
Bioethics in Canada, second edition (with C. Weijer eds) . Don Mills: Oxford University Press, 2019.
“Overriding Adolescent Refusals of Treatment" (with Lisa Forsberg & Isra Black), Journal of Ethics and Social Philosophy (forthcoming).
" Mandating Vaccination, " (with Lisa Forsberg). In The Ethics of Pandemics , ed. Meredith Celene Schwartz (Peterborough, ON: Broadview, 2020), 131-134.
" Practical Ethics in Sidgwick and Kant. " In Kantian and Sidgwickian Ethics: The Cosmos of Duty Above and the Moral Law Within, eds. Tyler Paytas & Tim Henning (New York: Routledge, 2020), 13-39.
"The Ethical Principles of Effective Altruism". In Journal of Global Ethics 12 (2):137-146 (2016).
"Late Utilitarian Moral Theory and Its Development: Sidgwick, Moore". In J. A. Shand (ed.), A Companion to Nineteenth-Century Philosophy (Blackwell Companions to Philosophy). Oxford: Wiley-Blackwell. pp. 281-310 (2019).
"Children and Wellbeing". In Anca Gheaus, Gideon Calder & Jurgen De Wispelaere (eds.), Routledge Handbook of the Philosophy of Childhood and Children. Abingdon, UK: Routledge. pp. 90-100 (2018).
Oxford Handbook of Isaac Newton (co-editor, with E. Schliesser). Oxford University Press. (Several entries published online, expected publication in fall 2021.)
“Determinism and General Relativity,” with Christian Wüthrich. Accepted in Philosophy of Science, preprint https://arxiv.org/abs/2009.07555.
"Validating the Universe in a Box," with Sarah C. Gallagher. Philosophy of Science 87 (5):1221-1233 (2020).
"Q.e.D., Qed" (with A. Koberinski). In Studies in History and Philosophy of Science Part B: Studies in History and Philosophy of Modern Physics 71:1-13 (2020).
"Some reflections on the structure of cosmological knowledge". In Studies in History and Philosophy of Science Part B: Studies in History and Philosophy of Modern Physics 71:220-231 (2020).
"The Cosmos As Involving Local Laws and Inconceivable without Them" (with Y. Benétreau-Dupin). In The Monist 100 (3):357-372 (2017).
“Gaining Access to the Early Universe,” in R. Dawid, K. ‘Thebault, and R. Darshati (eds.), Why Trust ŒTheory? Epistemology of Fundamental Physics. Cambridge: Cambridge University Press (2019), pp. 315-338.
"Philosophical Geometers and Geometrical Philosophers". In B. Hill, G. Gorham, E. Slowik & C. Kenneth Waters (eds.), The Language of Nature: Reassessing the Mathematization of Natural Philosophy in the Seventeenth Century. Minneapolis: University of Minnesota Press. pp. 308-338 (2016).
Discourse, Structure and Linguistic Choice (Springer, 2018).
Sourcebook in the History of Philosophy of Language (with M. Cameron & B. Hill eds.). Springer, 2017.
Linguistic Content: New Essays on the History of Philosophy of Language (with M. Cameron eds.). Oxford University Press, 2015.
"Slurs and register: A case study in meaning pluralism," with Diaz‐Legaspe, Justina and Liu, Chang. Mind and Language 35 (2):156-182 (2020).
"Emociones, ofensa y registro sociolingüístico: el caso de los “usos distantes” de los términos discriminatorios", (with J. Diaz Legaspe). In Critica 51 (153):3-29 (2020).
"Re-reading Anscombe on ‘I’". In Canadian Journal of Philosophy 49 (1):70-93 (2019).
"What Distinguishes Assertion?". In Proceedings of the XXIII World Congress of Philosophy 38:33-37, (2018).
"An Anscombean Reference for ‘I’?" (with A. Botterell). In Croatian Journal of Philosophy 18 (3):343-361 (2018).
"Logical Form and the Vernacular Revisited" (with A. Botterell). In Mind and Language 32 (4):495-522 (2017).
"Understanding Stability in Cognitive Neuroscience Through Hacking’s Lens." Philosophical Inquiries.
"New Frontiers in Translational Research: Touchscreens, Open Science, and The Mouse Translational Research Accelerator Platform (MouseTRAP)," with Julie R. Dumont, Sara Memar, Miguel Skirzewski, Jinxia Wan, Maryam H. Mofrad, Hassam Zafar Ansari, Yulong Li, Lyle Muller, Vania F. Prado, Marco A.M. Prado, Lisa M. Saksida, Timothy J. Bussey. Genes, Brain and Behavior (2021).
"Sensory inflow manipulation induces learning-like phenomena in motor behavior," with Samuele Contemori, Cristina V Dieni, Aldo Ferraresi, Chiara Occhigrossi, Francesco Calabrese, Vito E Pettorossi, Andrea Biscarini, Roberto Panichi. European journal of applied physiology 120: 811-828 (2020).
“Classification, Kinds, Taxonomic Stability, and Conceptual Change” (with J. Mattu). In Aggression and Violent Behavior(2020).
"Understanding Crime: A Mutilevel Approach" (with D. Ward). In Psychology, Crime & Law, 25(6): 709-711 (2020).
"Achieving Cumulative Progress in Understanding Crime: Some Insights from the Philosophy of Science". In Psychology, Crime & Law, 25(6): 561-576 (2019).
"Optogenetics, Pluralism and Progress". In Philosophy of Science 85 (00):1090-1101 (2018).
"Judging Mechanistic Neuroscience: A preliminary conceptual-analytic framework for evaluating scientific evidence in the courtroom" (with E. Baron). In Psychology, Crime and Law 24(3): 334-351 (2018).
"Coordinated Pluralism as a Means to Facilitate Integrative Taxonomies of Cognition". In Philosophical Explorations Issue 2: 129-145 (2017).
"Construct Stabilization and the Unity of the Mind-Brain Sciences". In Philosophy of Science 83: 662-673 (2016).
"Response to Commentary on Stabilizing constructs through collaboration across different research fields as a way to foster the integrative approach of the Research Domain Criteria (RDoC) Project". In Frontiers in Human Neuroscience (2016).
"Stabilizing constructs through collaboration across different research fields as a way to foster the integrative approach of the Research Domain Criteria (RDoC) Project". In Frontiers in Human Neuroscience (2016).
"Mechanisms in neuroscience", (with C. Stinson). Routledge Handbook of the Philosophy of Mechanisms, Stuart Glennan and Phyllis Illari (eds.). Routledge (2017).
“Long-term potentiation: One Kind or Many?”. In Eppur Si Muove: Doing History and Philosophy of Science: A Collection of Essays in Honor of Peter Machamer. Marcus Adams, Zvi Biener, Uljana Feest and Jackie Sullivan, eds., Springer. pp. 127-140 (2016).
“Models of Mental Illness”. In Harold Kincaid, Jeremy Simon & Miriam Solomon (eds.), The Routledge Companion to the Philosophy of Medicine. Routledge. pp. 455-464 (2016).
“Neuroscientific Kinds Through the Lens of Scientific Practice”. In Catherine Kendig (ed.), Natural Kinds and Classification in Scientific Practice. Routledge. pp. 47-56 (2016).
Journal Book Forum Contribution
Are there Model Behaviours for Model Organism Research? Commentary on Nicole Nelson's Model Behavior. Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences82:101266 (2020).
‘Aristotle’s Definition of Time: a modest proposal’, SAGP Newsletter,2016/17.3, 13-19
‘Aristotle on the Unity of Consciousness.’ in The Achilles of Rationalist Psychology, ed. Tom Lennon & Rob Stainton,
‘Splitting the Semantic Atom: Aristotle on compound nouns.’ Apeiron Vol. XLII, No. 2, June 2009, 153-166
‘Intelligible Matter in Aristotle’, SAGP Newsletter 2009/10.4, 15-20
"Primordial fluctuations from quantum gravity," (with Francesco Gozzini). Frontiers in Astronomy and Space Sciences, 7, 118, 2021 [arXiv:1906.02211]
"Pre-big-bang black-hole remnants and the past low entropy" (with C. Rovelli). Universe, 4(11), 129, 2018. [arXiv:1805.03224]
"Relational Quantum Cosmology". In "Philosophy of Cosmology". Ed. J. Barrow, K. Chamcham, J. Silk, S. Saunders. Cambridge University Press, 2017. [arXiv:1309.1403]
"Atomism and Relationalism as guiding principles for Quantum Gravity". PoS(FFP14)222, 2014. [arXiv:1309.1403]
"Covariant Loop Quantum Gravity. An elementary introduction to Quantum Gravity and Spinfoam Theory" (with C. Rovelli). Cambridge University Press, 2014.
“The philosopher’s paradox: How to make a coherent decision in the Newcomb Problem" (co-authored with C. Hoefer and D. Viger, 60% contribution). In Theoria. An International Journal for Theory, History and Foundations of Science, 34(3), 2019, 407-421 (2019).
“Two Questions about Interpretative Effects,” (co-authored with R. Stainton, 50% contribution). In Beyond Semantics and Pragmatics (Ed. G. Preyer). Oxford, UK: OUP, 2018: 9-31.
World Health Organization. Key criteria for the ethical acceptability of COVID-19 human challenge studies. Geneva: WHO, 2020. [Member of the Working Group for Guidance on Human Challenge Studies for COVID-19]
Placebo Comparison for Surgical Trials. Methods for Placebo Comparator Group Selection and Use on Surgical Trials and ASPIRE Guidance: Guidance for Researchers and Funder Representatives, with Beard DJ, Campbell MK, Blazeby JM, Carr AJ, Cuthbertson BH, Buchbinder R, Pinkney T, Bishop FL, Pugh J, Cousins S, Harris IA, Lohmander LS, Blencowe N, Gillies K, Probst P, Brennan C, Cook A, Farrar-Hockley D, Savulescu J, Huxtable R, Rangan A, Tracey I, Brocklehurst P, Ferreira ML, Nicholl J, Reeves BC, Hamdy F, Rowley SC, and Cook JA. Report to the Medical Research Council UK and the National Institute for Health Research UK. 2020. [43 pages]
World Health Organization. Ethical considerations for health policy and systems research. Geneva: WHO, 2019. [Lead writer]
Bioethics in Canada, second edition (with A. Skelton eds). Don Mills: Oxford University Press, 2019.
"Reopening schools safely in the face of COVID-19: Can cluster randomized trials help?," with Hemming K, Phillips Hey S, and Fernandez Lynch H. Clinical Trials 2021: 1740774520984860. doi: 10.1177/1740774520984860. [6 pages]
"The multiplicity of caregiving burden: a qualitative analysis of families with prolonged disorders of consciousness," with Gonzalez-Lara LE, Munce S, Christian J, Owen AM, and Webster F. Brain Injury 2021 Jan 1:1-9. doi: 10.1080/02699052.2020.1865565. [9 pages]
"The experiences of caregivers of individuals in a locked in, minimally conscious state, or vegetative state with the health care system," with Munce SEP, Webster F, Christian J, Gonalez-Lara LE, and Owen AM. Brain Injury 2020; December 31: DOI: 10.1080/02699052.2020.1858494. [7 pages]
"Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?," with McPartlin SO, Morrison J, and Rohrig A. British Medical Journal 2020; 371: m4258. [3 pages]
"Use of multiple period, cluster randomised, crossover trial designs for comparative effectiveness research," with Hemming K, Taljaard M, and Forbes AB. British Medical Journal 2020; 371: m3800. [8 pages]
"Loopholes in the research ethics system? Informed consent waivers in cluster randomized trials with individual-level interventions," with London AJ and Taljaard M. Ethics & Human Research 2020; 42(6): 21–28.
"Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group," Jamrozik E, Littler K, Bull S, Emerson C, Kang G, Kapulu M, Rey E, Saenz C, Shah S, Smith PG, Upshur R, and Selgelid MJ. Vaccine 2020: 39(4): 633–640.
"Ethical issues in the design and conduct of pragmatic cluster randomized trials in hemodialysis care: An interview study with key stakeholders," with Nicholls S, Carroll K, Goldstein C, Brehaut J, Sood M, Aljaishi A, Basile E, Grimshaw J, Garg A, and Taljaard M. Canadian Journal of Kidney Health and Disease. October 2020. doi: 10.1177/2054358120964119 [12 pages]
“Reporting of key methodological and ethical aspects of cluster trials in hemodialysis require improvement: a systematic review,” (with A.A. Al-Jaishi, K. Carroll, C.E. Goldstein, S.N. Dixon, A.X. Garg, S.G. Nicholls, J.M. Grimshaw, J. Brehaut, L. Thabane, P.J. Devereaux & M. Taljaard). In Trials 21, 2020: 752.
“Cluster over individual randomization: are study design choices appropriately justified? Review of a random sample of trials,” (with M. Taljaard, C.E. Goldstein, B. Giraudeau, S.G. Nicholls, K. Carroll, S.P. Hey, J.C. Brehaut, V. Jairath, A.J. London, S.M. Eldridge, J.M. Grimshaw & D.A. Fergusson). In Clinical Trials 17 (3), 2020: 253-263.
“Rules of the road for patient-driven consent processes,” (with H.P. Nix). In American Journal of Bioethics 20 (5), 2020: 36–37.
“Ethical issues in cluster randomized trials conducted in low- and middle-income countries: an analysis of two case studies,” (with A.T. Choko, G. Roshandel, D.F. Conserve, E.L. Corbett, K. Fielding, K. Hemming & R. Malekzadeh). In Trials 21 (Suppl 1), 2020: 314.
“Considerations and methods for placebo controls in surgical trials (ASPIRE guidelines),” (with D.J. Beard, M.K. Campbell, J.M. Blazeby, A.J. Carr, B.H. Cuthbertson, R. Buchbinder, T. Pinkney, F.L. Bishop, J. Pugh, S. Cousins, I.A. Harris, L.S. Lohmander, N. Blencowe, K. Gillies, P. Probst, C. Brennan, A. Cook, D. Farrar-Hockley, J. Savulescu, R. Huxtable, A. Rangan, I. Tracey, P. Brocklehurst, M.L. Ferreira, J. Nicholl, B.C. Reeves, F. Hamdy, S.C. Rowley & J.A. Cook). In The Lancet 395 (10226), 2020: 828–838.
“It does not matter whether research interventions are usual care,” (with C.E. Goldstein). In American Journal of Bioethics 20 (1), 2020: 47–48.
“Cultivating Innovative Pragmatic Cluster-Randomized Registry Trials Embedded in Hemodialysis Care: Workshop Proceedings from 2018,” (with E.J. Lee, A. Patel, R.R. Acedillo, J.C. Bachynski, I. Barrett, E. Basile, M. Battistella, D. Benjamin, D. Berry, P.G. Blake, P. Chan, C.J. Bohm, K.K. Clemens, C. Cook, L. Dember, J.S. Dirk, S. Dixon, E. Fowler, L. Getchell, N. Gholami, C. Goldstein, E. Hahn, B. Hogeterp, S. Huang, M. Hughes, M.J. Jardine, S. Kalatharan, S. Kilburn, E. Lacson Jr, S. Leonard, C. Liberty, C. Lindsay, J.M. MacRae, B.J. Manns, J. McCallum, C.W. McIntyre, A.O. Molnar, R.A. Mustafa, G.E. Nesrallah, M.J. Oliver, M. Pandes, S. Pandeya, M.S. Parmar, E.Z. Rabin, J. Riley, S.A. Silver, J.M. Sontrop, M.M. Sood, R.S. Suri, N. Tangri, T.J. Tascona, A. Thomas, R. Wald, M. Walsh, M.A. Weir, H. Vorster, D. Zimmerman, A.X. Garg & Gardener’s Grove Participants). In Canadian Journal of Kidney Health and Disease 6, 2019: 6:2054358119894394.
“The ethical challenges raised in the design and conduct of pragmatic trials. An interview study with key stakeholders,” (with S.G. Nicholls, K. Carroll, M. Zwarenstein, J.C. Brehaut, S.P. Hey, C.E. Goldstein, I.D. Graham, J. McKenzie, J.M. Grimshaw, D.A. Fergusson, M. Taljaard on behalf of the CIHR Ethics of Pragmatic Trials project). Trials 20, 2019: 765.
“Ethical issues in the design and conduct of stepped-wedge cluster randomized trials in low-resource settings,” (with K. Joag, G. Ambrosio, E. Kestler, K. Hemming & R. Van der Graaf. In Trials 20 (Suppl 2), 2019: 703.
“Towards the assessment of quality of life in in patients with disorders of consciousness,” (with J. Tung, K.N. Speechley, T. Gofton, L. Gonzalez-Lara, M. Graham, L. Naci, A.H. Peterson & A.M. Owen. In Quality of Life Research 29 (5), 2020: 1217-1227.
“Stepped-wedge trials should be classified as research for the purpose of ethical review,” (with K. Hemming, M. Taljaard, T. Marshall, & C.E. Goldstein). In Clinical Trials 16 (6), 2019: 580-588.
“Ottawa Statement does not impede randomised evaluation of government health programmes,” (with M. Taljaard). In Journal of Medical Ethics 46 (1), 2019, 31-33.
“The ethics of psychedelic research in disorders of consciousness,” (with A. Peterson & E. Tagliazucchi). In Neuroscience of Consciousness 5 (1), 2019: niz013.
“A stepwise approach to ethically assess pragmatic cluster randomized trials: implications for informed consent for suicide prevention implementation research,” (with C.E. Goldstein). In American Journal of Bioethics 19 (10), 2019: 101–103.
“Emergence of human immunoprofiling in health and disease,” (with B. Singh, K.L. Summers, G. Barker, E. Desjardins & J. Madrenas). In Current Trends in Immunology 19, 2019: 11–19.
“The ethics of cluster randomized trials: Response to a proposal for revision of the Ottawa Statement,” (with M. Taljaard). In Journal of Clinical Epidemiology 116, 2019: 140-145.
“Working for the weekend is not meaningful work,” (with M.S. Graham). In American Journal of Bioethics 19(9), 2019: 48-50.
“Ethical Issues in Pragmatic Cluster-Randomized Trials in Dialysis Facilities,” (with C.E. Goldstein, M. Taljaard, A.A. Al-Jaishi, E. Basile, J. Brehaut, C.L. Cook, J.M. Grimshaw, E. Lacson Jr, C. Lindsay, M. Jardine, L.M. Dember & A.X. Garg). In American Journal of Kidney Diseases 74 (5), 2019: 659-666.
“Ethical issues raised by cluster randomised trials conducted in low-resource settings: identifying gaps in the Ottawa Statement through an analysis of the PURE Malawi trial,” (with T.K. Mtande, M.C. Hosseinipour, M. Taljaard, M. Matoga, C.E. Goldstein, B. Nyambalo & N.E. Rosenberg). In Journal of Medical Ethics 45 (6), 2019: 388–393.
“Informed consent for functional MRI research on comatose patients following severe brain injury: balancing the social benefits of research against patient autonomy,” (with T. Bruni, M. Graham, L. Norton, T. Gofton & A.M. Owen). In Journal of Medical Ethics 45 (5), 2019: 299-303.
“Stakeholder views regarding ethical issues in the design and conduct of pragmatic trials: Study Protocol,” (with S.G. Nicholls, K. Carroll, J.C. Brehaut, S.P. Hey, C.E. Goldstein, M. Zwarenstein, I. Graham, J.E. McKenzie, L. McIntyre, V. Jairath, M.K. Campbell, J.M. Grimshaw, D.A. Fergusson & M. Taljaard). In BMC Medical Ethics 19, 2018: 90.
“Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration,” (with K. Hemming, M. Taljaard, J.E. McKenzie, R. Hooper, A. Copas, J.A. Thompson, M. Dixon-Woods, A. Aldcroft, A. Doussau, M. Grayling, C. Kristunas, C.E. Goldstein, M.K. Campbell, A. Girling, S. Eldridge, M.J. Campbell, R.J. Lilford, A.B. Forbes & J.M. Grimshaw). In British Medical Journal 363, 2018: k1614.
“Developing a framework for the ethical design and conduct of pragmatic trials to improve patient health and health system outcomes: Study protocol for a mixed methods study,” (with M. Taljaard, J.M. Grimshaw, A. Ali, J.C. Brehaut, M.K. Campbell, K. Carroll, S. Edwards, S. Eldridge, C.B. Forrest, B. Giraudeau, C.E. Goldstein, I. Graham, K. Hemming, S.P. Hey, A.R. Horn, V. Jairath, T.P. Klassen, A.J. London, S. Marlin, J.C. Marshall, L. McIntyre, J.E. McKenzie, S.G. Nicholls, P.A. Paprica, M. Zwarenstein & D.A. Fergusson). In Trials 19, 2018: 525.
“FLUID trial: a protocol for a hospital-wide open-label cluster crossover pragmatic comparative effectiveness randomised pilot trial,” (with L. McIntyre, M. Taljaard, T. McArdle, A. Fox-Robichaud, S.W. English, C. Martin, J. Marshall, K. Menon, J. Muscedere, D.J. Cook, R. Saginur, A. Maybee, A. Iyengar, A. Forster, I.D. Graham, S. Hawken, C. McCartney, A.J. Seely, I.G. Stiell, K. Thavorn & D.A. Fergusson DA). In BMJ Open 8 (8), 2018: e022780.
“Accommodating quality and service improvement research within existing ethical regulations,” (with C.E. Goldstein, J. Brehaut, M. Campbell, D. Fergusson, J.G. Grimshaw, K. Hemming, A.R. Horn & M. Taljaard). In Trials 9 (1), 2018: 334.
“Using neuroimaging to uncover awareness in brain-injured and anesthetized patients,” (with M. Graham, A.M. Owen, L. Naci). In Frontiers in Bioscience 10, 2018: 337–349.
“When and how should we cluster and cross over: methodological and ethical issues,” (with C.E. Goldstein, B. Giraudeau & M. Taljaard). In Canadian Journal of Anesthesia 65 (7), 2018: 760–765.
“Thinking Clearly About the FIRST Trial: Addressing ethical challenges in cluster randomized trials of policy interventions involving health providers,” (with A.R. Horn, S.P. Hey, J. Brehaut, D. Fergusson, C.E. Goldstein, J.G. Grimshaw & M. Taljaard). In Journal of Medical Ethics 44 (9), 2018: 593-598.
“Ethical implications of excessive cluster sizes in cluster randomized trials,” (with K. Hemming, M. Taljaard, G. Forbes & S. Eldridge). In BMJ Quality & Safety 27 (8), 2018: 664-670.
“An ethical analysis of the SUPPORT trial: addressing challenges posed by pragmatic comparative effectiveness randomized controlled trials with usual care interventions,” (with A.R. Horn, J.M. Grimshaw, J. Brehaut, D. Fergusson, C.E. Goldstein & M. Taljaard). In Kennedy Institute of Ethics Journal 28 (1), 2018: 85–117.
“Minimizing the harm of accidental awareness under general anesthesia: new perspectives from patients misdiagnosed as being in a vegetative state,” (with M. Graham, A.M. Owen, K. Çipi K & Naci L). In Anesthesia & Analgesia 126 (3), 2018; 1073–1076.
“Ethical issues in pragmatic randomized controlled trials: a review of the recent literature identifies gaps in ethical argumentation,” (with C.E. Goldstein, J.C. Brehaut, D. Fergusson, J.M. Grimshaw, A.R. Horn & M. Taljaard). In BMC Medical Ethics 19 (1), 2018: 14.
“Research ethics for emerging trial designs: does equipoise need to adapt?,” (with S.P. Hey, M. Taljaard & A.S. Kesselheim), In British Medical Journal 360, 2018: k226.
“TwiC or treat? Are Trials within Cohorts ethically defensible?,” (with C.E. Goldstein & M. Taljaard). In Clinical Trials 15 (1), 2018: 21-24.
“Is the concept of clinical equipoise still relevant to research?,” (with S.P. Hey, A.J. London, A. Rid & F. Miller). In British Medical Journal 359: 2017: j5787.
“Does consent form follow function?,” (with C.E. Goldstein & J. Brehaut J). In American Journal of Bioethics 17 (12), 2017: 29–31.
“When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework,” (with J. Jull, M. Whitehead, M. Petticrew, E. Kristjansson, J. Petkovic, J. Volmink, M. Taljaard, S. Edwards, L. Mbuagbaw, R. Cookson, J. McGowan, A. Lydiatt, Y. Boyer, L.G. Cuervo, R. Armstrong, H. White, M. Yoganathan, T. Pantoja, B. Shea, K. Pottie, O. Norheim, S. Baird, B. Robberstadt, H. Sommerfelt, Y. Asada, G. Wells, P. Tugwell & V. Welch). In BMJ Open 7, 2017: e015815.
“How to design efficient cluster randomised trials,” (with K. Hemming, S. Eldridge, G. Forbes & M. Taljaard). In British Medical Journal 358, 2017: j3064.
“Do doctors have a duty to take part in pragmatic randomised trials?,” (with M.K. Campbell, C.E. Goldstein & S.J.L. Edwards SJL). In British Medical Journal 357, 2017: j2817.
“Inadequacy of ethical conduct and reporting of stepped wedge cluster randomized trials: Results from a systematic review,” (with M. Taljaard, K. Hemming, L. Shah, B. Giraudeau & J.M. Grimshaw). In Clinical Trials14 (4), 2017: 333–341.
“Covert narrative capacity: Mental life in patients thought to lack consciousness,” (with L. Naci, M. Graham M & A.M. Owen). In Annals of Clinical and Translational Neurology 4 (1), 2016: 61–70.
“Assessing decision-making capacity in patients with communication impairments: a case study,” (with M. Cairncross, A. Peterson & A. Lazosky). In Cambridge Quarterly of Healthcare Ethics 25, 2016: 691–699.
“What questions can a placebo help answer?,” (with S.P. Hey). In Monash Bioethics Review 34 (1), 2016: 23-36.
“The ethics of future trials: qualitative analysis of physicians' decision making,” (with F. Webster, L. Todd, J.M. Grimshaw, A.P. Marshall, D. Cook, G. MacLennan, B.H. Cuthbertson, J.J. Francis for the SuDDICU International Group). In Trials 17 (1), 2016: 12.
“Clinical equipoise,” (with A.R. Horn). In Encyclopedia of Global Bioethics 2016: 1–11.
“Cluster randomized trials: a closer look,” (with A.M. McRae & M. Taljaard). In Clinical Trials 13 (3), 2016: 294–300.